OccuLogix, Inc.

OccuLogix, Inc.

July 21, 2005 16:10 ET

OccuLogix to Release Q2-05 Financial Results on August 4-Conference Call to Follow

TORONTO, ONTARIO--(CCNMatthews - July 21, 2005) - OccuLogix, Inc. (NASDAQ:RHEO)(TSX:RHE) will release its 2005 second quarter financial results before market open on Thursday, August 4, 2005.

OccuLogix is pleased to invite all interested parties to participate in a conference call during which the results will be discussed. The call will be held on August 4, at 8:00 a.m. Eastern Time. To access the live call, dial 800-470-5906 (within the United States and Canada), or 416- 620-2417 (international callers).

The call will be broadcast live and archived on the company's website at www.occulogix.com under the "webcasts" link in the Investor Relations section. In addition, the live web cast will be available at various other popular portals and financial web sites.

For those wishing to listen to a recording of the call via telephone, a replay will be made available as soon as possible after the conclusion of the live call and will remain posted for a period of seven days. To listen to the recording, simply telephone 416-626-4100 and enter reservation # 21253166 when prompted.

About OccuLogix, Inc.

OccuLogix is a health care company that brings innovative and evidenced-based medical therapies to market. OccuLogix's common shares trade on the NASDAQ National Market under the symbol 'RHEO' and on the Toronto Stock Exchange under the symbol 'RHE'.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian regulatory authorities, including our Registration Statement on Form S-1. We do not undertake to update any forward-looking statements.

Contact Information